UTHR
United Therapeutics Corporation Earnings
$284.73
Earnings Summary
Revenue | $735.9Mn |
Net Profits | $301.3Mn |
Net Profit Margins | 40.94% |
United Therapeutics Corporation’s revenue jumped 19.72% since last year same period to $735.9Mn in the Q4 2024. On a quarterly growth basis, United Therapeutics Corporation has generated -1.74% fall in its revenue since last 3-months.
United Therapeutics Corporation’s net profit jumped 38.78% since last year same period to $301.3Mn in the Q4 2024. On a quarterly growth basis, United Therapeutics Corporation has generated -2.52% fall in its net profits since last 3-months.
United Therapeutics Corporation’s net profit margin jumped 15.93% since last year same period to 40.94% in the Q4 2024. On a quarterly growth basis, United Therapeutics Corporation has generated -0.8% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 6.66 |
EPS Estimate Current Year | 6.66 |
United Therapeutics Corporation’s earning per share (EPS) estimates for the current quarter stand at 6.66 - a 6.27% jump from last quarter’s estimates.
United Therapeutics Corporation’s earning per share (EPS) estimates for the current year stand at 6.66.
Key Ratios
Earning Per Share (EPS) | 6.19 |
United Therapeutics Corporation’s earning per share (EPS) jumped 41.97% since last year same period to 6.19 in the Q4 2024. This indicates that the United Therapeutics Corporation has generated 41.97% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-02-26 | 6.27 | 6.19 | -1.23% |
2024-05-01 | 5.65 | 6.17 | 9.2% |
2024-10-30 | 6.43 | 6.39 | -0.62% |
2024-07-31 | 6.4 | 5.85 | -8.59% |
